I was reading back over the February 23, 2012 Patent announcement on the Neuroprotective Phylomer Peptide.
It says Phylogica have a patent issued for a neuroprotective, intracellular phylomer and that they did a deal with J&J last year for intracellular phylomers but it doesn't say the new phylomer is part of the J&J deal. Or is it? Craftily worded I would say.
I think they mentioned J&J to remind people that they've done a deal with J&J. The neuroprotective phylomer could well be of interest to J&J but it's years away from the
clinic and any potential uses of it are very speculative at this point. However, given the wide range of actions associated with AP-1, I'm sure J&J is screening it and other Phylogica proteins in a wide range of in vitro assay systems.
J&J seem to be moving into this field big time by the looks of it. They're driving the One Mind for Research program and I don't think they're doing that out of the goodness of their hearts.
GLTA!
- Forums
- ASX - By Stock
- finance news network interview 13 march
I was reading back over the February 23, 2012 Patent...
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $562 | 5.417K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 579525 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 219559 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 579525 | 0.100 |
3 | 126221 | 0.099 |
6 | 204204 | 0.098 |
2 | 38700 | 0.097 |
2 | 174000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 219559 | 7 |
0.110 | 1915319 | 11 |
0.115 | 404267 | 6 |
0.120 | 293847 | 5 |
0.125 | 150000 | 1 |
Last trade - 11.07am 21/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online